CDC Health Advisory: Highly Pathogenic Avian Influenza A(H5N1) Virus: Recommendations for Human Health Investigations and Response May 1, 2022 Highly Pathogenic Avian Influenza A(H5N1) Virus: Recommendations for Human Health Investigations and Response Summary A person has tested positive for avian ... Read More
CDC Health Advisory: Information on Treatments for Outpatients with Mild to Moderate COVID-19 at Risk for Severe Outcomes April 26, 2022 The Centers for Disease Control and Prevention (CDC) issued a Health Advisory to update healthcare providers about the availability ... Read More
CDC Health Advisory: Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology April 22, 2022 The Centers for Disease Control and Prevention (CDC) issued the health advisory below today. The full CDC Health Advisory ... Read More
Public Health Increasing Access to Second Booster Dose at Skilled Nursing Facilities April 12, 2022 With increased circulation of the more infectious BA.2 subvariant, the County Department of Public Health (Public Health) is ramping ... Read More
LAHAN - CDPH Health Update: Use of Outpatient COVID-19 Therapeutics in California April 1, 2022 The California Department of Public Health (CDPH) issued an update on the status of COVID-19 therapeutics in California, including ... Read More
With Gradual Increase of BA.2 Subvariant in LA County, Layering of Safety Protections Critical for Residents and Workers at Elevated Risk March 22, 2022 As multiple COVID metrics continue to decline, the state is lifting the requirements for vaccine and test verification at ... Read More
LAC DPH Health Advisory: Temporary National Shortage of Rifampin Oral Capsules March 3, 2022 Key Messages There is a temporary national shortage of rifampin oral capsules attributable to product discontinuations, equipment malfunction, and shortage ... Read More
LAC DPH Health Update: Revisions to Evusheld Dosing February 28, 2022 Key Messages The FDA has revised the emergency use authorization for Evusheld (tixagevimab plus cilgavimab) to increase the dose (from ... Read More
CAHAN Health Update: Distribution and Patient Prioritization for Tixagevimab/Cilgavimab (Evusheld) February 18, 2022 The California Department of Public Health (CDPH) issued a CAHAN on the distribution and patient prioritization for tixagevimab/cilgavimab (Evusheld). Evusheld ... Read More
LAC DPH Health Advisory: Availability of Therapeutics for Treatment and Pre-exposure Prophylaxis of COVID-19 February 11, 2022 Key Messages Four therapies are available to treat mild to moderate COVID-19 in individuals at high risk for progression to ... Read More
CDPH Health Alert Omicron Variant Update: Therapeutics Changes for Outpatient Treatment of Mild to Moderate COVID-19 February 4, 2022 The California Department of Public Health (CDPH) issued a CAHAN regarding changes in recommended outpatient therapies based on activity ... Read More
LAC DPH Health Advisory: Addressing Low COVID-19 Vaccination Rates in Children 5-11 Years of Age January 28, 2022 Key Messages The CDC, the American Academy of Family Physicians, and the American Academy of Pediatrics recommend that all children ages 5 years and ... Read More